Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: OraSure Technologies, Inc.

Market Cap 288M 250M 231M 216M 404M 27.62B 412M 2.75B 1.07B 13.31B 1.08B 1.06B 46.3B P/E Ratio 2026 *
-3.99x
P/E Ratio 2027 * -5.11x
Enterprise Value 288M 250M 231M 216M 404M 27.62B 412M 2.75B 1.07B 13.31B 1.08B 1.06B 46.3B EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.26x
Free-Float
93.62%
Yield 2026 *
-
Yield 2027 * -
1 day+3.97%
1 week+0.48%
Current month-2.56%
1 month+38.74%
3 months+31.76%
6 months+63.04%
Current year+73.14%
1 week 4
Extreme 4
4.3
1 month 2.92
Extreme 2.92
4.33
Current year 2.33
Extreme 2.33
4.33
1 year 2.08
Extreme 2.08
4.33
3 years 2.08
Extreme 2.08
8.45
5 years 2.08
Extreme 2.08
13.57
10 years 2.08
Extreme 2.08
23.01
Manager TitleAgeSince
Chief Executive Officer 52 2022-06-03
Director of Finance/CFO 54 2022-08-07
Chief Tech/Sci/R&D Officer - 2024-11-30
Director TitleAgeSince
Director/Board Member 59 2020-05-31
Director/Board Member 66 2021-11-07
Director/Board Member 52 2022-06-03
Date Insider Type Main position Quantity % Market Cap.
06-02Free

Chairman

46,106 0.0670%
06-02Free

Director

46,106 0.0670%
06-02Free

Director

46,106 0.0670%
Change 5-day change 1-year change 3-year change Capi.($)
+3.97%+0.48%+43.49%-20.34% 288M
+0.54%-1.24%-33.73%-11.84% 156B
+0.10%-1.95%-8.78%-4.06% 103B
+0.09%+4.13%-1.80%+57.94% 54.77B
+3.00%+0.30%+55.27%+51.53% 53.52B
-0.30%-1.48%-14.69%-41.41% 40.6B
+1.61%+7.78% - - 31.4B
+0.64%+3.66%-9.33%-39.48% 29.04B
-0.18%+4.10%+47.47%-5.15% 23.34B
-2.85%-3.53%-16.97%-1.50% 20.81B
Average +0.66%+1.51%+6.77%-1.59% 51.3B
Weighted average by Cap. +0.50%+0.39%-7.09%+1.41%

Financials

2026 *2027 *
Net sales 120M 104M 95.75M 89.71M 168M 11.46B 171M 1.14B 442M 5.52B 449M 440M 19.21B 128M 111M 102M 95.82M 179M 12.24B 183M 1.22B 472M 5.9B 480M 470M 20.52B
Net income -73.68M -63.94M -58.94M -55.22M -103M -7.05B -105M -703M -272M -3.4B -277M -271M -11.82B -57.65M -50.03M -46.11M -43.21M -80.73M -5.52B -82.41M -550M -213M -2.66B -216M -212M -9.25B
Net Debt - -
Logo OraSure Technologies, Inc.
OraSure Technologies, Inc. transforms health through actionable insight and decentralizes diagnostics to connect people to healthcare wherever they are. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.
Employees
500
Date Price Change Volume
26-06-11 4.190 $ +3.97% 776,017
26-06-10 4.030 $ -4.95% 716,979
26-06-09 4.240 $ +2.17% 748,278
26-06-08 4.150 $ +2.72% 808,637
26-06-05 4.040 $ -3.12% 554,823
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
4.190USD
Average target price
4.750USD
Spread / Average Target
+13.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OSUR Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!